SCHEMBL4002282

SCHEMBL4002282

C#Cc1ccc(C(=O)NC(CCSC)C(=O)Nc2ccc(N3CCOCC3=O)c(C)c2)s1

nearest known ligand 0.68

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
F10 P00742 19/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4008598 1.00 F10 (0.68) F10
SCHEMBL4002822 0.93 F10 (0.70) F10
SCHEMBL4009275 0.92 F10 (0.79) F10
SCHEMBL13767933 0.91 F10 (0.70) F10
SCHEMBL4005529 0.91 F10 (0.69) F10
SCHEMBL4005658 0.90 F10 (0.69) F10
SCHEMBL13764114 0.90 F10 (0.69) F10
SCHEMBL4001270 0.89 F10 (0.67) F10
SCHEMBL4319827 0.89 F10 (0.69) F10
SCHEMBL4003107 0.89 F10 (0.69) F10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7563786-B2 Substituted thiophenecarboxamides, their preparation and their use as medicaments BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-07-21 US claimed
US-20060069082-A1 Novel substituted thiophenecarboxamides, their preparation and their use as medicaments BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2006-03-30 US claimed
US-7563786-B2 Substituted thiophenecarboxamides, their preparation and their use as medicaments BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-07-21 US disclosed
US-20060069082-A1 Novel substituted thiophenecarboxamides, their preparation and their use as medicaments BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2006-03-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060069082-A1 Novel substituted thiophenecarboxamides, their preparation and their use as medicaments P2RY11, P2RX5, TPMT F10 2756/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.